<- Go Home

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Market Cap

DKK 98.1B

Volume

302.9K

Cash and Equivalents

DKK 817.0M

EBITDA

DKK 11.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

DKK 19.1B

Profit Margin

67.23%

52 Week High

DKK 646.60

52 Week Low

DKK 369.70

Dividend

5.28%

Price / Book Value

7.34

Price / Earnings

35.53

Price / Tangible Book Value

-7.02

Enterprise Value

DKK 121.1B

Enterprise Value / EBITDA

10.16

Operating Income

DKK 7.7B

Return on Equity

18.53%

Return on Assets

10.12

Cash and Short Term Investments

DKK 817.0M

Debt

DKK 23.8B

Equity

DKK 13.4B

Revenue

DKK 28.4B

Unlevered FCF

DKK 8.1B

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches